Pfizer Inc. is a global biopharmaceutical company engaged in the discovery, development, manufacture, and marketing of healthcare products. Its core business model focuses on innovative medicines and vaccines across various therapeutic areas, including oncology, cardiology, immunology, and infectious diseases. Pfizer is widely recognized for its development of the COVID-19 vaccine in collaboration with BioNTech, which significantly boosted its market presence and revenue streams.
As a large-cap company, Pfizer holds a strong position in the pharmaceuticals industry, competing with other major players such as Johnson & Johnson and Merck. The company is known for its diverse product portfolio, which includes well-established medications like Lipitor and Viagra, alongside its newer offerings. Pfizer has a reputation as a dividend-paying stock, appealing to income-focused investors while also pursuing growth through strategic acquisitions and partnerships.
Recently, Pfizer has shifted its strategic focus towards expanding its pipeline of mRNA-based therapies and enhancing its vaccine portfolio. The company is also investing in research and development to address unmet medical needs, positioning itself for long-term growth in an evolving healthcare landscape. This commitment to innovation and patient care underscores Pfizer's role as a leader in the biopharmaceutical sector.